The VETNOx management team has worked together since 2005 when they formed ANOxA CORP, a veterinary translational and clinical research company to commercialize their pioneering equine product, which is a patented treatment for Exercise Induced Pulmonary Haemorrhage
(EIPH) in performance horses. Working together they successfully developed it from concept stage to finished product, which led to licensing agreements to market and distribute it
throughout North America, as well as Australia, New Zealand, Saudi Arabia, Singapore and China.
This same team has now created VETNOx to focus on maturing other related technologies that address major animal health issues and represent large potential markets.